Please login to the form below
statins
This page shows the latest statins news and features for those working in and with pharma, biotech and healthcare.
Amarin shares tumble following Vascepa patent loss
It became the first US Food and Drug Administration (FDA)-approved drug to reduce cardiovascular risk in patients with elevated triglyceride levels as an add-on to maximally tolerated statin therapy.
Latest news
-
Esperion gets FDA thumbs up for cholesterol drug Nexletol
The US regulator has cleared Nexletol (bempedoic acid) as an add-on to diet and maximum-dose statin therapy for patients with atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH), ... C-reactive protein”
-
Novartis plans inclisiran trial in the UK
statins alone.
-
Novartis links up with NHS for speedy access to cholesterol drug inclisiran
statins. In phase 3 trials of the gene-silencing drug, inclisiran was able to significantly reduce levels of LDL cholesterol – so-called ‘bad cholesterol’ – and demonstrated absolute change in LDL cholesterol ... It has been tested for use in
-
Northsea Therapeutics raises $40m to develop fish oil NASH drug
Vascepa is the first FDA-approved drug to reduce cardiovasular risk among patients with elevated triglyceride levels as an add-on to maximally tolerated statin therapy.
-
FDA okays Amarin’s Vascepa for cardiovascular risk reduction
Vascepa (icosapent ethyl) becomes the first FDA-approved drug to reduce cardiovascular risk among patients with elevated triglyceride levels as an add-on to maximally tolerated statin therapy. ... The approval is based on the results of the REDUCE-IT
More from news
Approximately 11 fully matching, plus 216 partially matching documents found.
Latest Intelligence
-
Cortellis Drugs to Watch in 2020 report
It will face competition mainly from generic statins and PCSK9 inhibitor monoclonal antibodies.
-
A roadmap to the successful treatment of Alzheimer’s disease
This would create a similar situation to cardiovascular disease where we use cholesterol as a biomarker and give statins in a preventative mode.
-
Holding on to hope for Alzheimer’s advances
In terms of BACE, Prof Roberts said: “Although the drug companies would love to have a drug that you could take like statins against hypercholesterolaemia, to give long-term protection against
-
Does safety sell medicines?
Statins - the most widely prescribed medicines on the planet - might not have been the success story they are without high quality pharmacovigilance detecting the risk of rhabdomyolysis and linking it to
-
Delivering accessible healthcare
Examples of how OTC can help tackle these pressures include the greater availability of statins in some countries and treatments for sexually transmitted diseases that do not require a prescription.
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest from PMHub
-
Fake News is Bad for your Health
Millions of people take statins to reduce their risk of dying prematurely, but how would they feel if they were told that 67 people need to be treated to reduce one
-
Digital Marketing is no Substitute for Sound Strategic Marketing
To build equivalent marketing capabilities, pharmaceutical companies invested in training, processes and teams to create highly effective marketing machines, as illustrated by the ‘statin’ wars of the late 90’s/early
-
How do you define a biotech company?
benefit (eg: statins, PD-1s or TNFs).
-
The changing face of medical communications over the past 15 years
We used to work on products such as calcium-channel blockers, statins and ACE inhibitors.
-
The Missing Ingredient in Online Healthcare: Trust
topics, they may see a recommendation to check out an interactive quiz featuring key points of a statin’s label. And since the recommendation is relevant to one of their medical
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Gilead agrees $21bn buyout of Immunomedics
- New medical communications agency BOLDSCIENCE launches
- Moderna inks R&D agreements with Vertex and Chiesi
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- FDA approves Roche’s Actemra COVID-19 trial
- OPEN Health’s Digital team have won a Bronze Award at the PM Society Digital Awards 2020
- New restrictions announced as UK’s COVID-19 alert level is increased
- Keytruda plus chemotherapy cuts risk of death by 27% in advanced oesophageal cancer
- AZ/Merck's Lynparza improves survival in certain prostate cancers
- The flexible salesforce
- Navigating engagement and remote working during the pandemic
PMHub
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...
Latest intelligence
- Improve clinical trials through patient journey mapping
- Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
Quick links
Infographics
